FDA holds cybersecurity of medical devices workshop
The US Food and Drugs Administration (FDA) held a public workshop dealing with cybersecurity in medical devices. The purpose of the workshop was to discuss the newly released draft guidance ‘Content of Premarket Submissions for Management of Cybersecurity in Medical Devices’, especially the topic of cybersecurity bill of materials (CBOM). The guidance details recommendations such as: limiting data access only to reliable users and devices, improving security measures for data access, and securing data integrity and confidentiality. The public can comment on the guidance until 18 March 2019.
About author
DW Team
The GIP Digital Watch Observatory team, consisting of over 30 digital policy experts from around the world, excels in the fields of research and analysis on digital policy issues. The team is backed by the creative prowess of Creative Lab Diplo and the technical expertise of the Diplo tech team.
